You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Study finds primary-care doctors often overlook prostate cancer risk in Black men
- 2. Development and validation of a prostate cancer risk prediction model for the elevated PSA population
- 3. The predictive value of PSMA PET/CT in determining pathological upgrading of prostate cancer: A pooling up analysis
- 4. New hurdle seen to prostate screening: primary-care docs
- 5. SEPTEMBER IS PROSTATE CANCER AWARENESS MONTH: PROCURE PROTON THERAPY CENTER ENCOURAGES MEN TO LEARN ABOUT THEIR OPTIONS
- 6. Orthocell's Remplir used in nerve-sparing prostate cancer surgery
- 7. Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
- 8. Machine learning-based analysis identifies glucose metabolism-related genes ADPGK as potential diagnostic biomarkers for clear cell renal cell carcinoma
- 9. The paradoxical role of stem cells in osteosarcoma: from pathogenesis to therapeutic breakthroughs
- 10. ‘I was told I had two weeks to live' – why are so many young, fit, non-smoking women getting lung cancer?
Last updated at 18:08 GMT
Hot News Makers
Health/Pharma Companies
-
347558.52
-
268953.40
-
40734.76
-
28739.42
-
20915.44
-
17463.15
-
14600.27
-
12589.61
-
11101.75
-
10212.40
Drugs, Treatments, Trials
-
22460.54
-
8789.88
-
8089.10
-
4615.14
-
3463.44
-
2785.24
-
2549.32
-
2167.11
-
1319.61
-
1280.80
Last updated at 17:10 GMT
